# 0 Total No. of AEs

**Page range:** 26â€“27

```text
0
Total No. of AEs
36
5
12
0

27
Drug Safety Report No: 1132062
Adverse Events
MedDRA PT
Pralsetinib Treated Arm
(N=108)
Standard of Care
(N=104)
Grade 3-4 (%)
Grade 5 (%)
Grade 3-4 (%)
Grade 5 (%)
Note: The row per each MedDRA PT contains numbers and percentages of patients (within each
treatment arm), whereas the last row contains the total number of AEs.
Note for Pralsetinib Arm: 11 patients presented with more than one AE (9 patients with 2 AEs each and 2
patients with 3 AEs). Hence, a total of 41 AEs were reported in 28 patients.
Of these 36 Grade 3-4 AEs, 5 AEs were of Grade 4 severity with PTs as Sepsis (n=2) and Device related
infection, Urosepsis and Pneumocystis jirovecii pneumonia (n=1 each)
MedDRA Version 27.0
Clinical Output Source:
root/clinical_studies/RO7499790/CDT30380/BO42864/data_analysis/Adhoc_Analysis/prod/output/t_ae
_ctc_MAIN_SE.out
The most frequently reported PT with Grade 5 and Grade 3-4 infections was
Pneumonia8 (3/5; 60% and 13/34; 38.2% respectively).
The Grade 3-5 infection AEs in the pralsetinib arm have been described and analyzed in
the following Section 3.2.1.1 and Section 3.2.1.2.
```